GI Windows Medical Corp, a clinical-stage, privately-held medical device company, announced a $16.4 million Series A-1 financing. The financing attracted Johnson & Johnson Innovation – JJDC, Inc., along with Sonder Capital, GT Healthcare, JC Investco and one additional strategic investor.